Unknown

Dataset Information

0

Parkinson-associated risk variant in distal enhancer of ?-synuclein modulates target gene expression.


ABSTRACT: Genome-wide association studies (GWAS) have identified numerous genetic variants associated with complex diseases, but mechanistic insights are impeded by a lack of understanding of how specific risk variants functionally contribute to the underlying pathogenesis. It has been proposed that cis-acting effects of non-coding risk variants on gene expression are a major factor for phenotypic variation of complex traits and disease susceptibility. Recent genome-scale epigenetic studies have highlighted the enrichment of GWAS-identified variants in regulatory DNA elements of disease-relevant cell types. Furthermore, single nucleotide polymorphism (SNP)-specific changes in transcription factor binding are correlated with heritable alterations in chromatin state and considered a major mediator of sequence-dependent regulation of gene expression. Here we describe a novel strategy to functionally dissect the cis-acting effect of genetic risk variants in regulatory elements on gene expression by combining genome-wide epigenetic information with clustered regularly-interspaced short palindromic repeats (CRISPR)/Cas9 genome editing in human pluripotent stem cells. By generating a genetically precisely controlled experimental system, we identify a common Parkinson's disease associated risk variant in a non-coding distal enhancer element that regulates the expression of ?-synuclein (SNCA), a key gene implicated in the pathogenesis of Parkinson's disease. Our data suggest that the transcriptional deregulation of SNCA is associated with sequence-dependent binding of the brain-specific transcription factors EMX2 and NKX6-1. This work establishes an experimental paradigm to functionally connect genetic variation with disease-relevant phenotypes.

SUBMITTER: Soldner F 

PROVIDER: S-EPMC5042324 | biostudies-literature | 2016 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Parkinson-associated risk variant in distal enhancer of α-synuclein modulates target gene expression.

Soldner Frank F   Stelzer Yonatan Y   Shivalila Chikdu S CS   Abraham Brian J BJ   Latourelle Jeanne C JC   Barrasa M Inmaculada MI   Goldmann Johanna J   Myers Richard H RH   Young Richard A RA   Jaenisch Rudolf R  

Nature 20160420 7601


Genome-wide association studies (GWAS) have identified numerous genetic variants associated with complex diseases, but mechanistic insights are impeded by a lack of understanding of how specific risk variants functionally contribute to the underlying pathogenesis. It has been proposed that cis-acting effects of non-coding risk variants on gene expression are a major factor for phenotypic variation of complex traits and disease susceptibility. Recent genome-scale epigenetic studies have highlight  ...[more]

Similar Datasets

2016-04-20 | GSE71278 | GEO
| S-EPMC3010848 | biostudies-literature
| S-EPMC10616187 | biostudies-literature
| S-EPMC6408259 | biostudies-literature
| S-EPMC2781518 | biostudies-literature
| S-EPMC7839675 | biostudies-literature
| S-EPMC5984599 | biostudies-literature
| S-EPMC4970658 | biostudies-literature
| S-EPMC4268043 | biostudies-literature
| S-EPMC6243385 | biostudies-literature